The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To evaluate the effects of hepatitis B vaccine and immunoglobulin in newborn infants of mothers positive for hepatitis B surface antigen. DESIGN: Systematic review and meta-analysis of randomised clinical trials. DATA SOURCES: Electronic databases and hand searches. REVIEW METHODS: Randomised clinical trials were assessed for methodological quality. Meta-analysis was undertaken on three outcomes: the relative risks of hepatitis B occurrence, antibody levels to hepatitis B surface antigen, and adverse events. RESULTS: 29 randomised clinical trials were identified, five of which were considered high quality. Only three trials reported inclusion of mothers negative for hepatitis B e antigen. Compared with placebo or no intervention, vaccination reduced the occurrence of hepatitis B (relative risk 0.28, 95% confidence interval 0.20 to 0.40; four trials). No significant difference in hepatitis B occurrence was found between recombinant vaccine and plasma derived vaccine (1.00, 0.71 to 1.42; four trials) and between high dose versus low dose vaccine (plasma derived vaccine 0.97, 0.55 to 1.68, three trials; recombinant vaccine 0.78, 0.31 to 1.94, one trial). Compared with placebo or no intervention, hepatitis B immunoglobulin or the combination of plasma derived vaccine and hepatitis B immunoglobulin reduced hepatitis B occurrence (immunoglobulin 0.50, 0.41 to 0.60, one trial; vaccine and immunoglobulin 0.08, 0.03 to 0.17, three trials). Compared with vaccine alone, vaccine plus hepatitis B immunoglobulin reduced hepatitis B occurrence (0.54, 0.41 to 0.73; 10 trials). Hepatitis B vaccine and hepatitis B immunoglobulin seem safe, but few trials reported adverse events. CONCLUSION: Hepatitis B vaccine, hepatitis B immunoglobulin, and vaccine plus immunoglobulin prevent hepatitis B occurrence in newborn infants of mothers positive for hepatitis B surface antigen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Self-citationWhat is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Competing interests: none declared.
Hirsch, L. (2006) · Cited by 1,396
Vertical Transmission of Hepatitis B Antigen in Taiwan
Stevens, C. E., Beasley, R. P., Tsui, J., & Lee, W.-C. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504102921503 · Cited by 1,022
Beasley, R. P., CHIN-YUN LEE, G., Roan, C.-H., Hwang, L.-Y., Lan, C.-C., Huang, F.-Y., & Chen, C.-L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90624-4 · Cited by 813
Okada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., & Mayumi, M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941402 · Cited by 728
Oxford textbook of clinical hepatology
(2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80409-0 · Cited by 697
Immunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 667
THE e ANTIGEN AND VERTICAL TRANSMISSION OF HEPATITIS B SURFACE ANTIGEN
BEASLEY, R. P., TREPO, C., STEVENS, C. E., & SZMUNESS, W. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112370 · Cited by 611
Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual Men
Hadler, S. C., Francis, D. P., Maynard, J. E., Thompson, S. E., Judson, F. N., Echenberg, D. F., Ostrow, D. G., O'Malley, P. M., Penley, K. A., Altman, N. L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150401 · Cited by 608
Maternal mortality surveillance, United States, 1980-1985.
Koonin, L. M., Atrash, H. K., Rochat, R. W., & Smith, J. C. (1988) · PubMed · Cited by 509
Wong, V. W., Reesink, H., Ip, H. H., Nco Lelie, P., Reerink-Brongers, E., Yeung, C. Y., & Ma, H. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92388-2 · Cited by 480
A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
Szmuness, W., Stevens, C. E., Zang, E. A., Harley, E. J., & Kellner, A. (1981) · Hepatology · doi:10.1002/hep.1840010502 · Cited by 457
Immunization Practices Advisory Committee (1991) · PsycEXTRA Dataset · doi:10.1037/e546382006-001 · Cited by 398
Funk, M. L., Rosenberg, D. M., & Lok, A. S. F. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00304.x · Cited by 354
Hs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323
Risk of anaphylaxis after vaccination of children and adolescents.
Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team (2003) · PEDIATRICS · doi:10.1542/peds.112.4.815 · Cited by 320
Immunisation against infectious disease.
Citron, K. M., & Lunn, J. A. (1988) · BMJ · doi:10.1136/bmj.297.6660.1406 · Cited by 308
Hepatocellular Carcinoma and Hepatitis B Virus
Beasley, R., & Hwang, L.-Y. (1984) · Seminars in Liver Disease · doi:10.1055/s-2008-1040651 · Cited by 291
Beasley, P. R., Hwang, L.-Y., Stevens, C. E., Lin, C.-C., Hsieh, F.-J., Wang, K.-Y., Sun, T.-S., & Szmuness, W. (1983) · Hepatology · doi:10.1002/hep.1840030201 · Cited by 290
Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier Mothers
Beasley, R. P., & Hwang, L.-Y. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.2.185 · Cited by 280
Xu, Z.-Y., Liu, C.-B., Francis, D. P., Purcell, R. H., Gun, Z.-L., Duan, S.-C., Chen, R.-J., Margolis, H. S., Huang, C.-H., Maynard, J. E., et al. (1985) · Pediatrics · doi:10.1542/peds.76.5.713 · Cited by 203
Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers
Lee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004790.pub2 · Cited by 184
Self-citationOver a decade of experience with a yeast recombinant hepatitis B vaccine
Safary, A., & Francis, A. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00179-6 · Cited by 150
Ip, H. M. H., Wong, V. W., Lelie, P. N., Kuhns, M., & Reesink, H. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90003-2 · Cited by 126
Vaccines for preventing hepatitis B in health-care workers
Chen, W., & Gluud, C. N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000100.pub3 · Cited by 113
Self-citationLee, P., Lee, C., Huang, L., & Chang, M. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70398-5 · Cited by 111
Self-citationDynamics and impact of perinatal transmission of hepatitis B virus in North India
Nayak, N. C., Panda, S. K., Bhan, M. K., Guha, D., & Zuckerman, A. J. (1987) · Journal of Medical Virology · doi:10.1002/jmv.1890210205 · Cited by 111
DuVernoy, T. S., Braun, M. M., & the VAERS Working Group (2000) · PEDIATRICS · doi:10.1542/peds.106.4.e52 · Cited by 90
Bock, P. K. (1994) · Anthropology News · doi:10.1111/an.1994.35.7.6.1 · Cited by 78
Preventing and treating hepatitis B infection
Aggarwal, R., & Ranjan, P. (2004) · BMJ · doi:10.1136/bmj.329.7474.1080 · Cited by 76
Lee, C., Huang, L., Chang, M., Hsu, C.-Y., WU, S.-J., Sung, J., & Safary, A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199104000-00007 · Cited by 71
Self-citationYang, Y., Liu, C., CHEN, T.-J., Lee, M.-F., Chen, S.-H., Shih, H., & Chang, M. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073123.93220.a8 · Cited by 62
Lolekha, S., Warachit, B., Hirunyachote, A., Bowonkiratikachorn, P., West, D. J., & Poerschke, G. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00358-4 · Cited by 57
Safety of neonatal hepatitis B vaccine administration
Lewis, E. M., Shinefield, H. R., Woodruff, B. A., BLACK, S. B., Destefano, F. R., Chen, R. T., & Ensor, R. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200111000-00009 · Cited by 54
Niu, M. T., DAVIS, D. M., & ELLENBERG, S. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199609000-00007 · Cited by 54
Hepatitis B vaccination for patients with chronic renal failure
Schroth, R. J., Hitchon, C. A., Uhanova, J., Noreddin, A. M., Taback, S. P., Moffatt, M. E. K., & Zacharias, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003775.pub2 · Cited by 54
Update: Recommendations to Prevent Hepatitis B Virus Transmission—United States
(1995) · JAMA · doi:10.1001/jama.1995.03530080019016 · Cited by 50
Neonatal Deaths After Hepatitis B Vaccine: The Vaccine Adverse Event Reporting System, 1991-1998
Niu, M. T., Salive, M. E., & Ellenberg, S. S. (1999) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.153.12.1279 · Cited by 46
Erythropoietin. Biology and clinical applications
Tabbara, I. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.3.298 · Cited by 38
Hieu, N. T., Kim, K.-H., Janowicz, Z. A., & Timmermans, I. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00518-7 · Cited by 38
Assateerawatt, A., Tanphaichitr, V. S., Suvatte, V., et al. (1993) · PubMed · Cited by 34
Harris, A., Yong, K., & Kermode, M. (2001) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2001.tb00566.x · Cited by 33
Quantifying Adverse Drug Events: Are Systematic Reviews the Answer?
Etminan, M., Carleton, B., & Rochon, P. A. (2004) · Drug Safety · doi:10.2165/00002018-200427110-00001 · Cited by 30
Fisher, M. A., Eklund, S. A., James, S. A., & Lin, X. (2001) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00078-8 · Cited by 28
Japanese and American Reports of Randomized Trials: Differences in the Reporting of Adverse Effects
Hayashi, K., & Walker, A. M. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)80001-8 · Cited by 28
PONGPIPAT, D., Suvatte, V., & Assateerawatts, A. (1989) · PubMed · Cited by 24
Sehgal, A., Gupta, I., Sehgal, R., & Ganguly, N. K. (1992) · PubMed · Cited by 21
Halliday, M. L., KANG, L.-Y., Rankin, J. G., et al. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.3.564 · Cited by 18
Safety and Immunogenicity of a Yeast-Derived Recombinant Hepatitis B Vaccine in Bulgarian Newborns
Kojouharova, M., Teoharov, P., Bahtchevanova, T., et al. (2001) · Infection · doi:10.1007/s15010-001-1150-6 · Cited by 16
[Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City].
Liu, Z. G., Zhao, S. L., & Zhang, Y. X. (1995) · PubMed · Cited by 15
Screening assays for Transmissible Spongiform Encephalopathies (TSEs)
MacGREGOR, I. R. (2004) · Vox Sanguinis · doi:10.1111/j.1741-6892.2004.00443.x · Cited by 10
Hepatitis B prophylaxis for newborns of hepatitis B surface antigen-positive mothers
Lee, C., Gong, Y., Brok, J. S., Boxall, E. H., & Gluud, C. N. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004790 · Cited by 6
Self-citationHepatitis B vaccination for patients with chronic renal failure
Schroth, R., Hitchon, C., Uhanova, J., Zacharias, J., Noreddin, A. M., Taback, S. P., & Moffatt, M. (2002) · doi:10.1002/14651858.cd003775 · Cited by 5
Completeness of Safety Reporting in Randomized Trials: An Evaluation of 7 Medical Areas
Ioannidis, J. P. A., & Lau, J. (2001) · JAMA · doi:10.1001/jama.285.4.437 · Cited by 3
Cited by
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
“HepB vaccine or HBIG given alone are 75% and 71% effective in preventing perinatal HBV transmission, respectively; their combined efficacy is 94% (29,52,117).”
BackgroundWilliams, R., Aspinall, R., Bellis, M., Camps-Walsh, G., Cramp, M., Dhawan, A., Ferguson, J., Forton, D., Foster, G., Gilmore, S. I., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61838-9 · Cited by 602
Chronic hepatitis B virus infection
Seto, W.-K., Lo, Y.-R., Pawlotsky, J.-M., & Yuen, M.-F. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31865-8 · Cited by 555
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., Lens, S., Testoni, B., Lai-Hung Wong, G., & Russo, F. P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.018 · Cited by 437
Poon, D., Anderson, B. O., Chen, L.-T., Tanaka, K., Lau, W. Y., Van Cutsem, E., Singh, H., Chow, W. C., Ooi, L. L., Chow, P., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70241-4 · Cited by 410
Metadata
- Authors
- Lee, C., Gong, Y., Brok, J., Boxall, E. H., & Gluud, C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2006-01-27
- Volume
- 332
- Issue
- 7537
- Pages
- 328-336
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2077496122
- Cited by
- 402
- References
- 61
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.